216 related articles for article (PubMed ID: 23887211)
21. Ethosuximide and tremor in Parkinson's disease: a pilot study.
Pourcher E; Gomez-Mancilla B; Bédard PJ
Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060
[TBL] [Abstract][Full Text] [Related]
22. [Drug-induced parkinsonism].
Levin OS; Shindriaeva NN; Anikina MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):76-81. PubMed ID: 23096050
[No Abstract] [Full Text] [Related]
23. Atypical antipsychotics and parkinsonism.
Rochon PA; Stukel TA; Sykora K; Gill S; Garfinkel S; Anderson GM; Normand SL; Mamdani M; Lee PE; Li P; Bronskill SE; Marras C; Gurwitz JH
Arch Intern Med; 2005 Sep; 165(16):1882-8. PubMed ID: 16157833
[TBL] [Abstract][Full Text] [Related]
24. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
25. Parkinsonism with HIV infection.
Mirsattari SM; Power C; Nath A
Mov Disord; 1998 Jul; 13(4):684-9. PubMed ID: 9686775
[TBL] [Abstract][Full Text] [Related]
26. [Drug treatment of frequent disorders in patients with Parkinson's disease].
Martí Massó JF; Poza JJ; López de Munain A
Neurologia; 1996 Mar; 11(3):109-15. PubMed ID: 8695142
[TBL] [Abstract][Full Text] [Related]
27. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
28. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
Rondot P; Bathien N
Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
[No Abstract] [Full Text] [Related]
29. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
[TBL] [Abstract][Full Text] [Related]
30. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.
Bocola V; Fabbrini G; Sollecito A; Paladini C; Martucci N
J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):213-6. PubMed ID: 8708659
[TBL] [Abstract][Full Text] [Related]
31. [Neuroleptics and antidepressants].
Kojima T; Tada K
No To Shinkei; 1992 Dec; 44(12):1077-82. PubMed ID: 1363591
[No Abstract] [Full Text] [Related]
32. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
[No Abstract] [Full Text] [Related]
33. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Metzer WS; Paige SR; Newton JE
Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
[TBL] [Abstract][Full Text] [Related]
34. Movement disorders induced by psychiatric drugs that do not block dopamine receptors.
Friedman JH
Parkinsonism Relat Disord; 2020 Oct; 79():60-64. PubMed ID: 32871538
[TBL] [Abstract][Full Text] [Related]
35. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
36. Selegiline for neuroleptic-induced parkinsonism.
Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
[No Abstract] [Full Text] [Related]
37. Tardive parkinsonism in a bipolar patient: post-mortem examination supports a physiological rather than pathological dysfunction.
Won MS; Mikos A; Hurd M; Fernandez H; Eskin T; Romrell J; Okun MS
Neurocase; 2008; 15(1):66-9. PubMed ID: 19235627
[TBL] [Abstract][Full Text] [Related]
38. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
Giroud-Benítez JL; López-Suárez RM; Méndez-Chávez A; Vistorte-Pupo A; González-Torres R; López-Jaén I; Pradere-Pensado JC; Enriquez Lescano Gort L; Paz-Sendin L
Rev Neurol; 2001 Dec 1-15; 33(11):1095-7. PubMed ID: 11785039
[No Abstract] [Full Text] [Related]
39. The diagnosis and treatment of neuroleptic-induced Parkinsonism.
Hoffman BF
Hosp Community Psychiatry; 1981 Feb; 32(2):110-4. PubMed ID: 6115811
[TBL] [Abstract][Full Text] [Related]
40. Neurological complications of psychiatric drugs: clinical features and management.
Haddad PM; Dursun SM
Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():15-26. PubMed ID: 18098217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
